Predicting HIV-1 coreceptor usage with sequence analysis.
about
Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian childrenBioinformatic analysis of HIV-1 entry and pathogenesis.Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usageAnalysis of physicochemical and structural properties determining HIV-1 coreceptor usageHIV-1 epidemic in the Caribbean is dominated by subtype B.V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV.Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage.Semen-specific genetic characteristics of human immunodeficiency virus type 1 env.Tropism testing in the clinical management of HIV-1 infection.Adoption of an "open" envelope conformation facilitating CD4 binding and structural remodeling precedes coreceptor switch in R5 SHIV-infected macaques.Human immunodeficiency virus type 1 variants isolated from single plasma samples display a wide spectrum of neutralization sensitivityComparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotypingCo-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India.Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.Co-receptor usage and prediction of V3 genotyping algorithms in HIV-1 subtype B' from paid blood donors experienced anti-retroviral therapy in Chinese central province.An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patientsComparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment.Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.Correlation of the virological response to short-term maraviroc monotherapy with standard and deep-sequencing-based genotypic tropism prediction methods.Evolution of coreceptor utilization to escape CCR5 antagonist therapy.Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins.HIV-1 drug resistance mutations: an updated framework for the second decade of HAARTArginine insertion and loss of N-linked glycosylation site in HIV-1 envelope V3 region confer CXCR4-tropism.Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection.Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses.Dual-acting stapled peptides target both HIV-1 entry and assemblyChemokine receptors and other G protein-coupled receptors.HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.Adhesion and fusion efficiencies of human immunodeficiency virus type 1 (HIV-1) surface proteins.HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assaysEscape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy.Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.Identifying and quantifying genotypes in polyclonal infections due to single species.The co-receptor signaling model of HIV-1 pathogenesis in peripheral CD4 T cellsPotential limitation of CCR5 antagonists: drug resistance more often linked to CXCR4-utilizing than to CCR5-utilizing HIV-1.
P2860
Q21261525-07DBC9FD-3D7E-4A55-B3E1-F2B190D43526Q27693321-BB7A704E-B178-48A1-BD09-8857780D01D2Q28469177-9809C41E-4EAB-4912-B372-C9443E5DCF56Q28488611-66110273-745F-46D8-876D-1E396F994809Q30375505-69E07E76-F685-4E50-B4A7-5AA6A5D1B24DQ33509526-B2CB405F-FA7E-4A74-AC7D-65079746435CQ33521304-0AAA03ED-79EE-4CCF-A2BA-A85A7234A2CEQ33711003-5A66F0DA-90F1-45FD-8EFF-29C6EF3672D0Q33717839-1EE7C291-2C2E-44FF-BC02-02BDB4DD4FFFQ33869686-D8F50510-6A36-4FBD-A6D3-E1EEE588E45DQ33961448-0EA68C34-A8EF-4754-BF9C-323C52091B37Q33987391-D960EFA8-33BC-48A2-8F14-701CDA084D6DQ34008448-101B1BED-BD51-4FB4-9CA6-657F7CABFFC1Q34053466-E80CF6D2-894F-4F25-8313-F8A268AD669FQ34267043-2C428A80-DC0D-4561-B32A-61DB819B7099Q34332104-DFE49F45-0F8B-4E2C-AAD6-1B62A289B076Q34351378-05139C56-FD62-4C6E-A591-8D07A73F8410Q34431102-BEDA07FC-A47F-4461-9A40-E72F58C27067Q34481372-1E92C5AB-484F-4F08-B7E3-66D97A87440FQ34647858-542D68C3-C056-4383-B784-E68CF9F3B54AQ34671618-5C655466-A139-4462-91D7-88EB5C2A02B1Q35528569-CD4F950E-77F4-4CDC-B188-A775046B3777Q35806266-9521CBB5-3A16-409E-B04D-FF9E3D556935Q36003168-23D1405D-86B1-48FB-95B7-EB5C298F2A6FQ36424523-17AEA306-0D70-40EF-9608-FD458406140CQ36900010-81007451-35EB-4F5E-BB87-6B0082C3EA3FQ37080284-F86DB03B-CB2A-4AA7-B52A-3B9E2C048F89Q37163016-34CEB742-7161-4439-97CB-01FB65B5FB20Q37180837-62FD6035-A32F-4B4A-9F9B-CAE693AFA742Q37348096-2A24B706-9EDB-49E1-AACC-29488A91996EQ37429729-0E6D8F7E-CCDF-451B-BB25-BCCC68B82C64Q37525642-46ECD4AE-69C8-4448-99A8-4FE96E2CF565Q38936024-07DB4144-2F0C-46FB-A81D-C74B2DCD612FQ39075099-E390528C-E383-4EBF-A9C9-F871BAECBC86Q39487637-580E51EB-F618-435B-BC97-65FFE79FB655Q40109869-0E2B2C96-59F8-43B9-872B-E80AAD44D78FQ40344458-262989E4-4E37-4818-87AA-E80424E21D72Q40478956-8D2C7860-684E-4E05-A0BE-176915873766Q41975845-CF086535-6334-478B-98B8-65DF6A05D113Q43240839-0C864C96-9CC2-4D46-BFF7-0756F6A9E437
P2860
Predicting HIV-1 coreceptor usage with sequence analysis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Predicting HIV-1 coreceptor usage with sequence analysis.
@ast
Predicting HIV-1 coreceptor usage with sequence analysis.
@en
type
label
Predicting HIV-1 coreceptor usage with sequence analysis.
@ast
Predicting HIV-1 coreceptor usage with sequence analysis.
@en
prefLabel
Predicting HIV-1 coreceptor usage with sequence analysis.
@ast
Predicting HIV-1 coreceptor usage with sequence analysis.
@en
P1433
P1476
Predicting HIV-1 coreceptor usage with sequence analysis
@en
P2093
Angélique B van 't Wout
Mark A Jensen
P304
P577
2003-04-01T00:00:00Z